| Literature DB >> 22975816 |
Yuya Koda1, Takehiko Mori, Takayuki Shimizu, Jun Kato, Akiko Yamane, Ken Sadahira, Yuiko Tsukada, Kenji Yokoyama, Norisato Hashimoto, Yutaka Hattori, Shinichiro Okamoto.
Abstract
We herein report two patients (70- and 45-year-old men) with refractory multiple myeloma who developed paralytic ileus shortly after starting bortezomib therapy. Bortezomib (1.3 mg/m(2)) was given on days 1, 4, 8, and 11 with daily oral solution itraconazole or voriconazole. Twelve and 15 days after beginning the therapy, each patient developed paralytic ileus. Interestingly, no other signs of peripheral neuropathy such as fingertip numbness were observed at the onset of ileus. Sporadic cases of paralytic ileus after bortezomib therapy have been reported, most of which developed ileus after several courses of bortezomib therapy. Our cases developed paralytic ileus shortly after initiating bortezomib, strongly suggesting that autonomic neuropathy due to bortezomib was induced by the concomitant use of itraconazole or voriconazole.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22975816
Source DB: PubMed Journal: Rinsho Ketsueki ISSN: 0485-1439